Identification of a novel specific small-molecule melanocortin-2-receptor antagonist
The overproduction of adrenocorticotropic hormone (ACTH), in conditions such as Cushing’s disease and congenital adrenal hyperplasia (CAH), leads to significant morbidity. Current treatment with glucocorticoids does not adequately suppress plasma ACTH, resulting in excess adrenal androgen production...
Main Authors: | Rachel Forfar, Mashal Hussain, Puneet Khurana, Jennifer Cook, Steve Lewis, Dillon Popat, David Jackson, Ed McIver, Jeff Jerman, Debra Taylor, Adrian JL Clark, Li F Chan |
---|---|
Format: | Article |
Language: | English |
Published: |
Bioscientifica
2022-11-01
|
Series: | Endocrine Connections |
Subjects: | |
Online Access: | https://ec.bioscientifica.com/view/journals/ec/11/12/EC-22-0338.xml |
Similar Items
-
Pharmacological Modulation of Melanocortin 1 Receptor Signaling by Mrap Proteins in Xenopus tropicalis
by: Xiaolu Tai, et al.
Published: (2022-06-01) -
Identification of Regions Involved in the Physical Interaction between Melanocortin Receptor Accessory Protein 2 and Prokineticin Receptor 2
by: Maria Rosaria Fullone, et al.
Published: (2022-03-01) -
Observations on the evolution of the melanocortin receptor gene family: distinctive features of the melanocortin-2 receptor
by: Robert Michael Dores
Published: (2013-04-01) -
Functional Characterization of the Internal Symmetry of MRAP2 Antiparallel Homodimer
by: Meng Wang, et al.
Published: (2021-10-01) -
ACTH signalling and adrenal development: lessons from mouse models
by: Tatiana V Novoselova, et al.
Published: (2019-07-01)